Anne Menz

Hamburg, HH 20246, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

Journal: Diagnostics (Basel, Switzerland)

Published: February 16, 2026

Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.

Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.

Journal: Molecular medicine (Cambridge, Mass.)

Published: December 16, 2025

Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types.

Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types.

Journal: Virchows Archiv : an international journal of pathology

Published: November 04, 2025

Primary cutaneous B-cell lymphomas-an overview of established and novel aspects

Primary cutaneous B-cell lymphomas-an overview of established and novel aspects

Journal: Dermatologie (Heidelberg, Germany)

Published: October 06, 2025

Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.

Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.

Journal: Experimental and molecular pathology

Published: July 23, 2025

Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors.

Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors.

Journal: Cancer medicine

Published: July 22, 2025

In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibition.

In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibition.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 04, 2025

L1CAM/CD171 expression in human tumors and its association with tumor phenotype.

L1CAM/CD171 expression in human tumors and its association with tumor phenotype.

Journal: Acta oncologica (Stockholm, Sweden)

Published: April 11, 2025

Correction: High prevalence of p16 staining in malignant tumors.

Correction: High prevalence of p16 staining in malignant tumors.

Journal: PloS one

Published: January 24, 2025

Acneiform type of mogamulizumab-associated rash.

Acneiform type of mogamulizumab-associated rash.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: December 21, 2024

Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors.

Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors.

Journal: PloS one

Published: December 11, 2024

Brachyury expression is highly specific for chordoma: A tissue microarray study involving 14,976 cancers from 135 different tumor types and subtypes.

Brachyury expression is highly specific for chordoma: A tissue microarray study involving 14,976 cancers from 135 different tumor types and subtypes.

Journal: Annals of diagnostic pathology

Published: December 09, 2024

Showing 1-12 of 90

Last Updated: 09/26/2026